SCHEMBL6886529

SCHEMBL6886529

O=c1c2ccccc2sc2ccc(I)cc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.64
ALDH1A1 P00352 7/20 0.58
MAPT P10636 6/20 0.58
RAB9A P51151 4/20 0.58
NPC1 O15118 3/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
GPR3 P46089 1/20 0.46
HPGD P15428 4/20 0.46
HCRTR1 O43613 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
POLB P06746 2/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31319901 1.00 KDM4E (0.64) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL24401456 0.89 KDM4E (0.54) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL7912381 0.84 GPR3 (0.61) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL18636123 0.84 KDM4E (0.54) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL5019890 0.82 KDM4E (0.69) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL28268803 0.82 KDM4E (0.68) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL9160474 0.82 GPR3 (0.68) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL29374932 0.82 GPR3 (0.68) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL30515127 0.82 GPR3 (0.68) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL36332 0.82 GPR3 (0.68) KDM4EALDH1A1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220251106-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2022-08-11 US disclosed
US-20220140249-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2022-05-05 US disclosed
US-20220025199-A1 RADIATION CURABLE INKJET INK FOR MANUFACTURING PRINTED CIRCUIT BOARDS AGFA-GEVAERT NV (BE) 2022-01-27 US disclosed
WO-2004089529-A1 METHOD FOR THE INTRAMOLECULAR ENERGY TRANSFER FOR THE CLEAVAGE OF LABILE FUNCTIONAL GROUP FROM BIOMOLECULES AND THE PROTECTED BIOMOLECULES Universität Konstanz (DE) 2004-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220140249-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CDYL, MRPL38, CDYL2 KDM4E 3526/4885ALDH1A1 1697/4885MAPT 3483/4885
US-20220251106-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE OR51E2, TAS2R38, SOD1 KDM4E 4454/4885ALDH1A1 1459/4885MAPT 2879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.